Navigation Links
New technology could revolutionize breast cancer screening
Date:11/11/2008

The world's first radar breast imaging system developed at Bristol University that could revolutionise the way women are scanned for breast cancer, is being trialled at North Bristol NHS Trust (NBT).

Professor Alan Preece and Dr Ian Craddock from the University of Bristol have been working for a number of years to develop a breast-imaging device which uses radio waves and therefore has no radiation risk unlike conventional mammograms.

The team began developing and researching a prototype around five years ago and have received funding from organisations including the Engineering and Physical Sciences Research Council (EPSRC), the trustees of the United Bristol Hospitals and the University of Bristol spin-out company, Micrima Ltd.

Dr Ian Craddock from the University's Department of Electrical and Electronic Engineering, said: "This new imaging technique works by transmitting radio waves of a very low energy and detecting reflected signals, it then uses these signals to make a 3D image of the breast. This is basically the same as any radar system, such as the radars used for air traffic control at our airports."

Mike Shere, Associate Specialist Breast Clinician at NBT, added: "Currently women are diagnosed in three ways: firstly by a clinician then by using imaging such as mammography and ultrasound and lastly by a needle biopsy.

"The radar breast imaging system came to Frenchay in September this year and so far around 60 women have been examined using it.

"It takes less time to operate than a mammogram approximately six minutes for both breasts compared with 30-45 minutes for an MRI, and like an MRI it provides a very detailed 3D digital image.

"Women love it as they compare it to a mammogram and find the whole experience much more comfortable."

The radar breast imaging system is built using transmitters and receivers arranged around a ceramic cup, which the breast sits in. These transmitt
'/>"/>

Contact: Joanne Fryer
joanne.fryer@bristol.ac.uk
44-117-331-7276
University of Bristol
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Reliant Technologies, and Palomar Medical Technologies, Announce Launch of a Fractional Technology Licensing Program
2. Palomar Medical Technologies and Reliant Technologies Announce Launch of a Fractional Technology Licensing Program
3. Use of Imaging Technology Skyrockets
4. Velocity Emerges as Healthcare Technology Leader
5. Misys Wins Best Trade Processing Product Accolade in European Banking Technology Readers Choice Awards
6. Birdstep Technology Announced the Addition of the TACT Group to its Family of Distributors
7. Cirrus Health and Siemens Announce Technology Alliance to Deliver the Physician-Driven Hospital of the Future
8. Central California Doctors Now Using Fast RapidArc(TM) Radiotherapy Technology to Battle Cancer
9. LifeNet Health Receives FDA Clearance for New Cardiovascular Technology
10. Mayo Clinics new imaging technology accurately identifies a broad spectrum of liver disease
11. Accuray Incorporated Ranked Fifth in Deloittes Technology Fast 50 Program for Silicon Valley Scientific/Medical Equipment, and Biotechnology Companies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2009)...n Whitaker, MD, a founder of the alternative healt...tpain.com, a new informational Web site devoted to...lutions. , Potomac, MD (V...er of the alternative health movement, is now a fe...ational Web site devoted to all aspects of joint a...
(Date:7/3/2009)...e health care reform details emerge, more entrepre...ll groups and business insurance premiums. Now, th...sites such as the Small Business Health Insurance ... Minneapolis, Minn. (PRWEB) July 3, 2009 -- The...he House, which has entrepreneurs worried about ho...
(Date:7/2/2009)...rs to Support Principles to Govern Health Insurer ...wire-USNewswire/ -- Nearly nine out of ten voters ... too much influence over how doctors care for thei...rt the concept of a "Health Insurer Code of Conduc...es for health insurance companies with respect to ...
(Date:7/2/2009)...RNewswire-USNewswire/ -- Acetaminophen is an ingre...ion medicines to help relieve pain and reduce feve...name, Tylenol and prescription brand names, Vicodi...the FDA met on June 30, 2009 to address liver rela... committee voted 20-17 to urge the FDA to put a ba...
Breaking Medicine News(10 mins):Health News:Dr. Julian Whitaker Featured on Searchjointpain.com 2Health News:Health Care Reform Details Emerge with 'Play or Pay' Requirements, Leaving Some Wondering about Small Business Owner Insurance 2Health News:Health Care Reform Details Emerge with 'Play or Pay' Requirements, Leaving Some Wondering about Small Business Owner Insurance 3Health News:4 out of 5 CA Voters Demand Health Insurer "Code of Conduct" 2Health News:4 out of 5 CA Voters Demand Health Insurer "Code of Conduct" 3Health News:4 out of 5 CA Voters Demand Health Insurer "Code of Conduct" 4Health News:4 out of 5 CA Voters Demand Health Insurer "Code of Conduct" 5Health News:4 out of 5 CA Voters Demand Health Insurer "Code of Conduct" 6Health News:Viles & Beckman, LLC: Stop Your Headache NOT Your Liver 2
..., a bacterium commonly found in hospitals, is beco...reat,// reports the April 2007 issue of Harvard Wo...t a new, more virulent strain may be to blame. Ce...oxins that attack the cells lining the colon. Thos...
...ry patients are more likely to suffer infections a...ng to cardiothoracic surgeons in Victoria. Dr Che...m St Vincent's hospital inMelbourne, and colleague...rtery bypass grafting or heart valvesurgery are 1....
... to predict whether a person is likely to have cor...h carried out by Dr. M. Balasubramanyam and Dr.V.M...ndia) shows that people who are pre-diabetic or wh...s1 and, since these people are prone to CAD, an ea...
...kal’ that is aimed for the diabetics, obese and th... India Pharma - USV Ltd//. Cutkal has a combinatio...is the same that is used in diet colas around the ...1981 and is used in 6,000 products like beverages,...
Other Medicine News:Health News:Obese Heart Patients At Greater Risk 2Health News:New Genetic Biomarkers Could Predict Coronary Heart Disease 2
(Date:6/30/2009)...Newswire/ -- Calixa Therapeutics Inc. today announ...CXA-101 in patients with complicated urinary tract...enteral cephalosporin antibiotic with excellent i...as aeruginosa , including drug resistant isolates....reatment for serious bacterial infections in hospi...
(Date:6/29/2009)...s to Assess RSV Burden in Outpatient Setting Durin...diatric Research , , GAITHERSBURG, Md., June ...its commitment to pediatric research with today,s ...e study designed to assess the burden of respirato...to-35 weeks gestational age (GA) in outpatient set...
(Date:6/29/2009)...al surgery patients achieved primary and secondary...RNewswire/ -- AcelRx Pharmaceuticals, Inc. today a...clinical study evaluating the safety and efficacy ...gement of acute post-operative pain in patients re...ompared to placebo, patients receiving ARX-01 Sufe...
(Date:6/29/2009)...nd, June 29 Vantia Therapeutics, a...l, small molecule drugs,targeting large, underser...om,a Phase IIa clinical trial of its lead develop...owed that oral VA106483 was successful in producin...t in patients, as determined by,increased osmolal...
Breaking Medicine Technology:Calixa Therapeutics Announces Initiation of Phase 2 Clinical Trial of Its Antibiotic, CXA-101, in Patients with Complicated Urinary Tract Infections 2MedImmune Funds Study to Help Gain Insights Into Full Burden of RSV Disease Among Premature Infants 2AcelRx Announces Positive Phase 2 Results from a Study of ARX-01 Sufentanil NanoTabs in Treating Post-Operative Pain 2AcelRx Announces Positive Phase 2 Results from a Study of ARX-01 Sufentanil NanoTabs in Treating Post-Operative Pain 3AcelRx Announces Positive Phase 2 Results from a Study of ARX-01 Sufentanil NanoTabs in Treating Post-Operative Pain 4Vantia Therapeutics' Lead Candidate VA106483 Demonstrates Positive Anti-diuretic Effect in Phase IIa Trial in Nocturia 2Vantia Therapeutics' Lead Candidate VA106483 Demonstrates Positive Anti-diuretic Effect in Phase IIa Trial in Nocturia 3Cadence Pharmaceuticals to Present at the Cowen and Company 28th Annual Health Care Conference on March 20 2008 in Boston 3961 1Cadence Pharmaceuticals to Present at the Cowen and Company 28th Annual Health Care Conference on March 20 2008 in Boston 3961 2The Stay Strong Foundation Launches National Healing Starts With US Campaign With Celebrity Guests Denzel Washington Ruby Dee MoNique Terry McMilla 14367 1The Stay Strong Foundation Launches National Healing Starts With US Campaign With Celebrity Guests Denzel Washington Ruby Dee MoNique Terry McMilla 14367 2The Stay Strong Foundation Launches National Healing Starts With US Campaign With Celebrity Guests Denzel Washington Ruby Dee MoNique Terry McMilla 14367 330 National Organizations Issue Call to Action for Congress to Fully Fund Falls Prevention Programming in CDC Budget 14364 130 National Organizations Issue Call to Action for Congress to Fully Fund Falls Prevention Programming in CDC Budget 14364 230 National Organizations Issue Call to Action for Congress to Fully Fund Falls Prevention Programming in CDC Budget 14364 3JCI online early table of contents 3A March 13 2008 14362 1JCI online early table of contents 3A March 13 2008 14362 2JCI online early table of contents 3A March 13 2008 14362 3JCI online early table of contents 3A March 13 2008 14362 4JCI online early table of contents 3A March 13 2008 14362 5JCI online early table of contents 3A March 13 2008 14362 6JCI online early table of contents 3A March 13 2008 14362 7
...IEW, Calif., June 05, 2007 /PRNewswire/ -- MAP,Pha...esent Phase 2,data from its MAP0004 migraine thera...adache Society Meeting at the Hyatt Regency,Chicag...hich was,accepted as a late-breaker, is entitled R... Inhaled Dihydroergotamine Mesylate,via a Novel In...
...British Columbia--(BUSINESS WIRE)--Jun 7, 2007 - A...May 23, 2007 press,release related to cryopreserve...aboration with the University of Helsinki,Finland...ls,designed to determine whether AAGP(TM) treated ...ation (4 degrees C)., Commenting on the results, P...
Other Medicine Technology:MAP Pharmaceuticals to Present MAP0004 Phase 2 Clinical Data at the,American Headache Society Meeting 2Refrigerated Stem Cells Survive 12 Times Longer with ProtoKinetix's,AAGP 2
The Wide-Vu magnifier is our most popular Low Vision telescope for reading. It offers a wide field of view than the LVA21 and hence a slightly shorter working distance. The Wide-Vu can be mounted to
The Redi-glaze spectacle magnifier is an aspheric lens, glazed into a standard Keeler LVA frame.
This set is designed to introduce the low vision practitioner to the Keeler telescopic system.
Featuring up to 20 tilting tower illumination allows examination in the vertical, horizontal and oblique sections plus the option to offset the slit for corneal transillumination., ,Filters inclu
Medicine Products: